PEG-Loxenatide

polyethylene glycol loxenatide · Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PEG-Loxenatide, covering 2013-11-06 to 2013-11-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes [Phase 1]

See pricing